Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER ; volume:120 ; number:7 ; day:4 ; month:12 ; year:2012 ; pages:1069-1081 ; date:7.2013
Journal of neural transmission ; 120, Heft 7 (4.12.2012), 1069-1081, 7.2013
- Creator
-
LeWitt, Peter A.
Boroojerdi, Babak
Surmann, Erwin
Poewe, Werner
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00702-012-0925-5
- URN
-
urn:nbn:de:101:1-2019080123440191756058
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- LeWitt, Peter A.
- Boroojerdi, Babak
- Surmann, Erwin
- Poewe, Werner
- SpringerLink (Online service)
Other Objects (12)
Transdermal rotigotine for the perioperative management of Parkinson’s disease
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
Parkinson
Parkinson
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Transdermal rotigotine for the perioperative management of Parkinson’s disease
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
Parkinson
Parkinson
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Transdermal rotigotine for the perioperative management of Parkinson’s disease
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
Parkinson
Parkinson